Peripheral Routes to Neurodegeneration: Passing Through the Blood–Brain Barrier

por Giannoni, Patrizia, Claeysen, Sylvie, Noe, Francesco, Marchi, Nicola
Publicado 2020

Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's Disease

por Giannoni, Patrizia, Fossati, Silvia, Marcello, Elena, Claeysen, Sylvie
Publicado 2020

Novel and atypical pathways for serotonin signaling

por Bockaert, Joël, Bécamel, Carine, Chaumont-Dubel, Séverine, Claeysen, Sylvie, Vandermoere, Franck, Marin, Philippe
Publicado 2021

Modifying Ligand-Induced and Constitutive Signaling of the Human 5-HT(4) Receptor

por Chang, Wei Chun, Ng, Jennifer K., Nguyen, Trieu, Pellissier, Lucie, Claeysen, Sylvie, Hsiao, Edward C., Conklin, Bruce R.
Publicado 2007

A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT(4)R) Agonist and Serotonergic S...

por Hatat, Bérénice, Yahiaoui, Samir, Lecoutey, Cédric, Davis, Audrey, Freret, Thomas, Boulouard, Michel, Claeysen, Sylvie, Rochais, Christophe, Dallemagne, Patrick
Publicado 2019

Phosphorylation of β-arrestin2 at Thr(383) by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs

por Cassier, Elisabeth, Gallay, Nathalie, Bourquard, Thomas, Claeysen, Sylvie, Bockaert, Joël, Crépieux, Pascale, Poupon, Anne, Reiter, Eric, Marin, Philippe, Vandermoere, Franck
Publicado 2017

SAP97-mediated ADAM10 trafficking from Golgi outposts depends on PKC phosphorylation

por Saraceno, C, Marcello, E, Di Marino, D, Borroni, B, Claeysen, S, Perroy, J, Padovani, A, Tramontano, A, Gardoni, F, Di Luca, M
Publicado 2014

Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT(4) receptors activities for the treatment of Alzheimer’s disease

por Lalut, Julien, Payan, Hugo, Davis, Audrey, Lecoutey, Cédric, Legay, Rémi, Sopkova-de Oliveira Santos, Jana, Claeysen, Sylvie, Dallemagne, Patrick, Rochais, Christophe
Publicado 2020

Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease

por Giannoni, Patrizia, Gaven, Florence, de Bundel, Dimitri, Baranger, Kevin, Marchetti-Gauthier, Evelyne, Roman, François S., Valjent, Emmanuel, Marin, Philippe, Bockaert, Joël, Rivera, Santiago, Claeysen, Sylvie
Publicado 2013

Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease

por Toublet, François-Xavier, Lecoutey, Cédric, Lalut, Julien, Hatat, Bérénice, Davis, Audrey, Since, Marc, Corvaisier, Sophie, Freret, Thomas, Sopkova de Oliveira Santos, Jana, Claeysen, Sylvie, Boulouard, Michel, Dallemagne, Patrick, Rochais, Christophe
Publicado 2019